elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38892486-1E16E56B-67C3-4F28-9FDC-BF9442EA162E
Q38892486-1E16E56B-67C3-4F28-9FDC-BF9442EA162E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38892486-1E16E56B-67C3-4F28-9FDC-BF9442EA162E
Targeting pathways mediating resistance to anti-EGFR therapy in squamous cell carcinoma of the head and neck.
P2860
Q38892486-1E16E56B-67C3-4F28-9FDC-BF9442EA162E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38892486-1E16E56B-67C3-4F28-9FDC-BF9442EA162E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e77d2dcdb09db7088069251aba202eb9cac29c1e
P2860
Sym004: a novel synergistic anti-epidermal growth factor receptor antibody mixture with superior anticancer efficacy.